BCR-ABL-independent and RAS / MAPK pathway-dependent form of imatinib resistance in Ph-positive acute lymphoblastic leukemia cell line with activation of EphB4.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples